CD79A and COVID-19: In particular, scientific research has focused on the role of mucosal IgA antibodies in the protection from infection, which have been shown to be implicated in the prevention of COVID-19 [26,36], with some authors suggesting that mucosal markers could represent a true mechanistic CoP, while serum titers could be merely non-mechanistic CoP [37].